Skip to main content

PharmacoEconomics

Ausgabe 8/2011

Inhalt (8 Artikel)

Editorial

The Case for Less, Not More, US FDA Regulation

John A. Vernon, Joseph H. Golec

Practical Application

Cost-of-Illness Studies

Allison Larg, John R. Moss

Review Article

Using QALYs in Cancer

Martina Garau, Koonal K. Shah, Anne R. Mason, Qing Wang, Adrian Towse, Michael F. Drummond

Short Communication

US FDA Modernization Act, Section 114

Peter J. Neumann, Pei-Jung Lin, Tom E. Hughes

Original research Article

Cost Estimation of Cardiovascular Disease Events in the US

Amy K. O’Sullivan, Jaime Rubin, Joshua Nyambose, Andreas Kuznik, David J. Cohen, David Thompson

Original Research Article

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis

Annette C. Reboli, Coleman Rotstein, Daniel H. Kett, Michael Maschio, Shannon Cartier, Richard Chambers, Miriam Tarallo